{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:57Z","timestamp":1791357537303,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.neuropharm.2013.02.024","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T14:20:54Z","timestamp":1363184454000},"page":"338-347","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in\u00a0vitro and in models of depression and anxiety"],"prefix":"10.1016","volume":"70","author":[{"given":"A.L.","family":"Auclair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"Assi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Heusler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cussac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Newman-Tancredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Depoort\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2013.02.024_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mpr.138","article-title":"The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) surveys","volume":"12","author":"Andrade","year":"2003","journal-title":"Int. J. Methods Psychiatry Res."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00213-009-1560-1","article-title":"Chronic oral nicotine increases brain [3H]epibatidine binding and responsiveness to antidepressant drugs, but not nicotine, in the mouse forced swim test","volume":"205","author":"Andreasen","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.neures.2009.10.009","article-title":"Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats","volume":"66","author":"Bardin","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1017\/S1461145709000236","article-title":"Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression","volume":"12","author":"Berrocoso","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1017\/S1461145708008766","article-title":"Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice","volume":"12","author":"Berrocoso","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/026988110201600403","article-title":"Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study","volume":"16","author":"Beyer","year":"2002","journal-title":"J.\u00a0Psychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2013.02.024_bib7","first-page":"15","article-title":"The noradrenergic symptom cluster: clinical expression and neuropharmacology","volume":"7","author":"Blier","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib8","first-page":"348","article-title":"An improved colorimetric technique for protein measurement","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/NDT.S13171","article-title":"Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors","volume":"6","author":"Briley","year":"2010","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib10","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0893-133X(01)00298-6","article-title":"Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in\u00a0vitro and in\u00a0vivo, human serotonin receptor subtypes, and other neuronal receptors","volume":"25","author":"Bymaster","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib11","series-title":"Methods of Behaviour Analysis in Neuroscience","first-page":"103","article-title":"Behavioral assessment of antidepressant activity in rodents","author":"Castagne","year":"2009"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib12","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/sj.npp.1300209","article-title":"Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study","volume":"28","author":"Chalon","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib13","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2010"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1461145705006413","article-title":"Differential physiological effects of a low dose and high doses of venlafaxine in major depression","volume":"10","author":"Debonnel","year":"2007","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.106.103382","article-title":"Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor","volume":"318","author":"Deecher","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib16","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-5347(25)00278-2","article-title":"Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in\u00a0vivo dialysis) in the rat","volume":"241","author":"Dennis","year":"1987","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1755-5949.2010.00146.x","article-title":"Relevance of norepinephrine-dopamine interactions in the treatment of major depressive disorder","volume":"16","author":"El Mansari","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib18","unstructured":"FDA Guidance on the Development of New Stereoisomeric Drugs, 1992. http:\/\/www.fda.gov\/drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/ucm122883.htm#.UKHEWm4ZyYE.email."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib19","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1476-5381.1995.tb15919.x","article-title":"Interaction between a selective 5-HT1A receptor antagonist and an SSRI in\u00a0vivo: effects on 5-HT cell firing and extracellular 5-HT","volume":"115","author":"Gartside","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.57.5.503","article-title":"Evidence of the dual mechanisms of action of venlafaxine","volume":"57","author":"Harvey","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib21","first-page":"7","article-title":"The chiral switch: the development of single enantiomer drugs from racemates","volume":"50","author":"Hutt","year":"2003","journal-title":"Acta Facult. Pharm. Univ. Comenianae"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0166-4328(02)00321-2","article-title":"22-kHz ultrasonic vocalization in rats as an index of anxiety but not fear: behavioral and pharmacological modulation of affective state","volume":"141","author":"Jelen","year":"2003","journal-title":"Behav. Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2013.02.024_bib23","first-page":"21","article-title":"Improvement of the noradrenergic symptom cluster following treatment with milnacipran","volume":"7","author":"Kasper","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib24","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-3565(25)24303-8","article-title":"Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex","volume":"272","author":"Kihara","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0028-3908(03)00268-5","article-title":"Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats","volume":"45","author":"Koch","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.pnpbp.2007.05.002","article-title":"Effect of various classes of antidepressants in behavioral paradigms of despair","volume":"31","author":"Kulkarni","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.neuroscience.2005.09.031","article-title":"Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability","volume":"137","author":"Lapiz","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1023648923447","article-title":"Enhancement of antidepressant potency by a potentiator of AMPA receptors","volume":"23","author":"Li","year":"2003","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib30","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0022-3565(24)29415-5","article-title":"S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine","volume":"298","author":"Millan","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0028-3908(85)90157-1","article-title":"Biochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drug","volume":"24","author":"Moret","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib33","first-page":"1","article-title":"Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [11C]DASB and (S, S)-[18F]FMeNER-D2","author":"Nogami","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"Suppl. E1","key":"10.1016\/j.neuropharm.2013.02.024_bib34","first-page":"4","article-title":"Relationship of neurotransmitters to the symptoms of major depressive disorder","volume":"69","author":"Nutt","year":"2008","journal-title":"Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0022-3565(24)37161-7","article-title":"Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites","volume":"283","author":"Owens","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib36","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.biopsych.2007.03.027","article-title":"Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents","volume":"62","author":"Papakostas","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"8.10A","key":"10.1016\/j.neuropharm.2013.02.024_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/0471142301.ns0810as14","article-title":"Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice","volume":"55","author":"Porsolt","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib38","first-page":"51","article-title":"Adrenergic involvement in the locus ceruleus and adjoining regions in the facilitation of predatory attack behavior as induced by hypothalamic stimulation in cats","volume":"48","author":"Saha","year":"2004","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(03)01277-9","article-title":"Stress-induced vocalisation in adult animals. A valid model of anxiety?","volume":"463","author":"Sanchez","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0160-5402(86)90006-9","article-title":"Pharmacological evaluation of the isolated rat seminal vesicle preparation","volume":"15","author":"Sharif","year":"1986","journal-title":"J.\u00a0Pharmacol. Methods"},{"issue":"Suppl. 4","key":"10.1016\/j.neuropharm.2013.02.024_bib41","first-page":"25","article-title":"Serotonin norepinephrine reuptake inhibitors: similarities and differences","volume":"16","author":"Shelton","year":"2009","journal-title":"Prim. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib42","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pbb.2005.01.007","article-title":"Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130","volume":"80","author":"Taber","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0893-133X(00)00220-7","article-title":"Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects","volume":"24","author":"Turcotte","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib45","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2003.07.006","article-title":"Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity","volume":"55","author":"Vaishnavi","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib46","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/026988110401800311","article-title":"The role of alpha1- and alpha2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus","volume":"18","author":"Weikop","year":"2004","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib47","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1517\/13543784.7.10.1691","article-title":"Duloxetine (LY 248686): an inhibitor of serotonin and noradrenaline uptake and an antidepressant drug candidate","volume":"7","author":"Wong","year":"1998","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuropharm.2013.02.024_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0003-2697(02)00435-9","article-title":"Simultaneous determination of norepinephrine, serotonin, and 5-hydroxyindole-3-acetic acid in microdialysis samples from rat brain by microbore column liquid chromatography with fluorescence detection following derivatization with benzylamine","volume":"312","author":"Yoshitake","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2013.02.024_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneumeth.2011.08.044","article-title":"Characterization of [3H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive","volume":"203","author":"Zhen","year":"2012","journal-title":"J.\u00a0Neurosci. Methods"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390813000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:26:55Z","timestamp":1745972815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390813000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":49,"alternative-id":["S0028390813000968"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2013.02.024","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}